Operation Warp Speed Remdesivir

Video and transcript below.

Operation warp speed remdesivir. Friday afternoon president donald trump provided an update on operation warp speed the program to mitigate covid 19 impacts in the us. 100000 pooled from va hospitals and through participating pharmaceutical company recruitment efforts in the coming months. The fda announced the expanded use of remdesivir at 520 pm. When we launched operation warp speed ows the unprecedented effort to produce and deliver safe and effective covid 19 vaccines to americans in record time skeptics questioned the viability of.

Its beautiful out here this time of year. To include therapeutics a vaccination for the virus. Operation warp speed will use government resources to quickly test the worlds most promising experimental vaccines in animals then launch coordinated human clinical trials to winnow down the candidates. The projects goal is to cut out the slow part the people said.

So operation warp speeds mission is to enable and accelerate the development of vaccines and therapeutics to help control the covid 19 pandemic and save lives. The goal is to prove out both efficacy and safety in record time with the lead candidates ferreted out by the end of 2020. Transcript the president. Vaccine development is typically slow and high risk.

In july my administration reached an agreement with pfizer to provide 195 billion. Thank you very much. Operation warp speed will pull together drug makers government agencies and the military to try to cut development time for a vaccine by as much as eight months. Et on friday citing the studies.

As part of the arrangement. Operation warp speed is a partnership among components of the department of health and human services and the department of defense engaging with private firms and other federal agencies and coordinating among existing hhs wide efforts to accelerate the development manufacturing and distribution of covid 19 vaccines therapeutics and diagnostic. Operation warp speeds goal is to produce and deliver 300 million doses of safe and effective vaccines with the initial doses available by january 2021 as part of a broader strategy to accelerate the development manufacturing and distribution of covid 19 vaccines therapeutics and diagnostics collectively known as countermeasures.